|
www.aurobindo.com |
|
|
|
MEB Netherlands approves
Lisinopril Tablets of Aurobindo |
|
|
Aurobindo Pharma Limited (Reuters
Code: ARBN.BO) is delighted to announce that
it has received the marketing authorization
approval from Medicines Evaluation Board (MEB),
NETHERLANDS for Lisinopril 10, 20, 30 and 40 mg
tablets. |
|
This is the fourth formulation
approval received from MEB, NETHERLANDS for a
product developed in house by Aurobindo, and
sixth such approval in Europe as a whole. With
this approval, it will be easier for Aurobindo
to obtain similar marketing authorization for
Lisinopril tablets in the other countries of the
European Union through Mutual Recognition
Procedure. |
|
Lisinopril is the generic version
of Zestril marketed by Astra Zeneca.
Lisinopril Dihydrate is an
effective, long acting orally administered
ACE inhibitor. It is used often in the
management of Hypertension. |
|
Aurobindo has already filed 36
products in various EU countries, some of which
are nearing the marketing authorization
approvals. Many more filings in the EU countries
are in pipeline in the coming year. |
|
Lisinopril in Europe has a market
of over 300 mio US dollars. |
|
About Aurobindo Pharma Limited: |
|
Aurobindo Pharma Limited (www.aurobindo.com),
headquartered at Hyderabad, India, manufactures
generic pharmaceuticals and active
pharmaceutical ingredients. The company’s robust
product portfolio is spread over 6 major
therapeutic/product areas encompassing
(Antibiotics, Anti-Retrovirals, CVS/ Statins/Diabetology,
CNS, Gastro/Uro/Kidney therapeutics, Anti
fungal/ allergics/respiratory)
The Company markets its products
in over 100 countries. The company has filed
over 86 ANDAs and 110 DMFs for the USA market,
in addition to several filings in other
countries. The company has received approvals
for several facilities from leading regulatory
agencies like US FDA, UK MHRA, WHO, Health
Canada, MCC South Africa. |
For further information,
please contact:
Investor Relations
Aurobindo Pharma Limited
Plot # 2, Maitri Vihar | Ameerpet
Hyderabad - 500 038 |India
Phone (Board): +91 40 6672 5000
Mobile 0 98486 67906
Email : ir@aurobindo.com |
|
|
|
|
|
|
|
|
|
PRESS
ROOM
